Role of iron in neurotoxicity: a cause for concern in the elderly?

被引:73
作者
Stankiewicz, James M. [1 ]
Brass, Steven D. [1 ,2 ]
机构
[1] Partners MS Ctr, Dept Neurol, Brigham & Womens Hosp, Brookline, MA 02445 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
关键词
Alzheimer's disease; iron; Parkinson's disease; stroke; EARLY PARKINSON-DISEASE; REDOX-ACTIVE IRON; NEURODEGENERATIVE DISEASE; ALZHEIMER-DISEASE; OXIDATIVE STRESS; OXYGEN RADICALS; BRAIN; ACCUMULATION; METABOLISM; RISK;
D O I
10.1097/MCO.0b013e32831ba07c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To explore the role of iron physiology in the brain of healthy adults and review how increased brain iron deposition has been associated with common neurodegenerative diseases that affect the elderly. Recent findings Because iron plays a role in oxygen transportation, myelin synthesis, neurotransmitter production, and electron transfers, it serves as a crucial cofactor in normal central nervous metabolism. However, an increased level of brain iron may promote neurotoxicity due to free radical formation, lipid peroxidation, and ultimately, cellular death. Advanced neuroimaging techniques and pathological studies have demonstrated increased brain iron with aging, and increased iron deposition has also been observed in patients with a constellation of neurological diseases, including Alzheimer's disease, Parkinson's disease, and stroke. Summary Pathologic and neurologic imaging coupled with experimentation have increased our understanding of the link between iron and neurodegeneration. A potential implication is that disease-modifying therapies aimed at removing excess iron may one day be part of the armamentarium employed by clinicians to decrease the burden of neurodegenerative diseases in the elderly.
引用
收藏
页码:22 / 29
页数:8
相关论文
共 71 条
[1]   The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study [J].
Abo-Krysha, N. ;
Rashed, L. .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (05) :602-608
[2]  
Aguirre P, 2006, BIOL RES, V39, P103
[3]   Metals in Alzheimer's and Parkinson's diseases [J].
Barnham, Kevin J. ;
Bush, Ashley I. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) :222-228
[4]   Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia [J].
Becker, E ;
Richardson, DR .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (01) :1-10
[5]   The oxidative neurotoxicity of clioquinol [J].
Benvenisti-Zarom, L ;
Chen, J ;
Regan, RF .
NEUROPHARMACOLOGY, 2005, 49 (05) :687-694
[6]   Human Aβ1-42 reduces iron-induced toxicity in rat cerebral cortex [J].
Bishop, GM ;
Robinson, SR .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (03) :316-323
[7]   Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: A stereological study [J].
Bostanci, M. Oemer ;
Bagirici, Faruk .
NEUROTOXICOLOGY, 2008, 29 (01) :130-135
[8]  
Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4
[9]   Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys [J].
Cass, Wayne A. ;
Grondin, Richard ;
Andersen, Anders H. ;
Zhang, Zhiming ;
Hardy, Peter A. ;
Hussey-Andersen, Lindsay K. ;
Rayens, William S. ;
Gerhardt, Greg A. ;
Gash, Don M. .
NEUROBIOLOGY OF AGING, 2007, 28 (02) :258-271
[10]   Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation [J].
Chinnery, Patrick F. ;
Crompton, Douglas E. ;
Birchall, Daniel ;
Jackson, Margaret J. ;
Coulthard, Alan ;
Lombes, Anne ;
Quinn, Niall ;
Wills, Adrian ;
Fletcher, Nicholas ;
Mottershead, John P. ;
Cooper, Paul ;
Kellett, Mark ;
Bates, David ;
Burn, John .
BRAIN, 2007, 130 :110-119